These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6284636)

  • 1. Studies on the interrelation of resistance and immunity in a mouse model system of herpes-simplex type 2 infection.
    Armerding D
    Immunobiology; 1982 May; 161(5):415-28. PubMed ID: 6284636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B; Allison AC
    J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of natural killer cells by herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains.
    Armerding D; Rossiter H
    Immunobiology; 1981; 158(4):369-79. PubMed ID: 6263793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
    Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearanc of cytotoxic cells within the bronchus after local infection with herpes simplex virus.
    Clancy R; Rawls WE; Jagannath S
    J Immunol; 1977 Sep; 119(3):1102-5. PubMed ID: 197165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NK cells in protection of mice against herpes simplex virus-1 infection.
    Rager-Zisman B; Quan PC; Rosner M; Moller JR; Bloom BR
    J Immunol; 1987 Feb; 138(3):884-8. PubMed ID: 3805719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
    Schrier RD; Ishioka GY; Pizer LI; Moorhead JW
    J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
    Kohl S; Thomas JW; Loo LS
    J Immunol; 1986 Apr; 136(8):3038-44. PubMed ID: 3007609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections.
    Deshpande SP; Kumaraguru U; Rouse BT
    Cell Immunol; 2000 Jun; 202(2):79-87. PubMed ID: 10896767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
    J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.
    Habu S; Akamatsu K; Tamaoki N; Okumura K
    J Immunol; 1984 Nov; 133(5):2743-7. PubMed ID: 6207244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo.
    Kohl S; Loo LS; Schmalstieg FS; Anderson DC
    J Immunol; 1986 Sep; 137(5):1688-94. PubMed ID: 3528287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.